TNFSF13 and melanoma: Hence, this small pilot study supports a paradigm for studying expression of a 3 TLS-kine index (APRIL/TNFSF13, CXCL10 and CXCL13) in serum that may predictive presence of histologically defined LA and/or TLS in the TME of melanoma patients.